valuat warrant second look upgrad buy
set pt upcom data catalyst
share recent slid upgrad share
neutral buy current ev/ntm revenue valuat feel investor
reward quarterli beat enthusiasm ahead
converg data fundament improv open busi
stabil atriclip continu gain momentum disappoint
lack converg data mani expect year
appreci mgmt reason conservat around fda timelin
co like hold data fda panel one think
key appropri set investor expect expect
better success rate propel mi adopt set
pt base share trade mo sale estim
improv oper open busi
exceed expect expect surgic avr procedur declin
shift take time estim less atrc open
procedur tie surgic avr atriclip street
adequ model step-down strong growth
uptak higher-pr product may pad growth management
call revenu growth see potenti upsid
concern converg per se expect lead
investor let lack converg data
particularli management outlin expect receiv one-
year efficaci data summer understand wait potenti
fda panel slightli longer timelin allow attract
entri point view feel endovascular procedur averag
doctor hand work time think success
converg drive commerci adopt one
speaker last analyst day hope higher think
import investor expect set correctli
valuat pt base mo sale estim
mirror averag valuat last year risk page
btig estim compani document million except per share amount
pleas read import disclosur analyst certif appear appendix
last year share trade
averag valuat yesterday close share trade
exhibit ev ntm sale valuat
rate buy pt base month revenu
estim in-lin trade rang last year current
valuat feel investor reward quarterli beat
open surgeri atriclip busi trend better expect
although disappoint lack data catalyst believ
manag conserv expect around fda timelin
appropri final expect investor interest could heighten near
data though key risk manag street expect reason
success physician train surgic procedur salesforc product
open-heart surgeri volum fda volatil ou result share shift
away surgic ablat procedur litig
exhibit comp tabl fast-grow med-tech compani
inc ingnnot factset data btig estimatespr ex-amortcompanytickerr ptpricemarket cap
atricur incom research gener expens incom pre-tax incom tax net incom dilut ep share net incom tax expens incom amort compens adjust ebitda margin y/i chang analysi good research gener net incom tax btig estim compani report
statesest open-heart procedur open-heart ablat ablat mi procedur mi asp invas ablat atriclip procedur atriclip asp ablat tool unit open-heart procedur ou open-heart ablat ablat mi procedur ou mi ablat atriclip procedur ou atriclip ablat atriclip tool btig estim compani provid dollar revenu per segment procedur price detail present model estim base compani commentari
btig cover compani mention report
appendix analyst certif import disclosur
